vs
Side-by-side financial comparison of FRANKLIN STREET PROPERTIES CORP (FSP) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $20.6M, roughly 1.3× Entrada Therapeutics, Inc.). FRANKLIN STREET PROPERTIES CORP runs the higher net margin — -28.1% vs -84.4%, a 56.3% gap on every dollar of revenue. On growth, FRANKLIN STREET PROPERTIES CORP posted the faster year-over-year revenue change (-8.2% vs -65.2%). FRANKLIN STREET PROPERTIES CORP produced more free cash flow last quarter ($-12.7M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -8.7%).
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
FSP vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $20.6M |
| Net Profit | $-7.3M | $-17.3M |
| Gross Margin | 59.4% | — |
| Operating Margin | -27.9% | -106.0% |
| Net Margin | -28.1% | -84.4% |
| Revenue YoY | -8.2% | -65.2% |
| Net Profit YoY | 14.1% | -173.8% |
| EPS (diluted) | $-0.06 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | — | ||
| Q3 25 | $27.3M | — | ||
| Q2 25 | $26.7M | — | ||
| Q1 25 | $27.1M | $20.6M | ||
| Q4 24 | $28.4M | $37.4M | ||
| Q3 24 | $29.7M | $19.6M | ||
| Q2 24 | $30.8M | $94.7M | ||
| Q1 24 | $31.2M | $59.1M |
| Q4 25 | $-7.3M | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $-7.9M | — | ||
| Q1 25 | $-21.4M | $-17.3M | ||
| Q4 24 | $-8.5M | $1.1M | ||
| Q3 24 | $-15.6M | $-14.0M | ||
| Q2 24 | $-21.0M | $55.0M | ||
| Q1 24 | $-7.6M | $23.5M |
| Q4 25 | 59.4% | — | ||
| Q3 25 | 60.9% | — | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 59.7% | — | ||
| Q3 24 | 61.0% | — | ||
| Q2 24 | 64.2% | — | ||
| Q1 24 | 64.7% | — |
| Q4 25 | -27.9% | — | ||
| Q3 25 | -30.5% | — | ||
| Q2 25 | -29.2% | — | ||
| Q1 25 | -78.9% | -106.0% | ||
| Q4 24 | -29.9% | -15.7% | ||
| Q3 24 | -52.4% | -110.7% | ||
| Q2 24 | -68.0% | 56.4% | ||
| Q1 24 | -24.0% | 35.7% |
| Q4 25 | -28.1% | — | ||
| Q3 25 | -30.5% | — | ||
| Q2 25 | -29.5% | — | ||
| Q1 25 | -79.1% | -84.4% | ||
| Q4 24 | -30.0% | 3.0% | ||
| Q3 24 | -52.6% | -71.7% | ||
| Q2 24 | -68.2% | 58.1% | ||
| Q1 24 | -24.2% | 39.7% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.08 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.21 | $-0.42 | ||
| Q4 24 | $-0.09 | $-0.20 | ||
| Q3 24 | $-0.15 | $-0.35 | ||
| Q2 24 | $-0.20 | $1.55 | ||
| Q1 24 | $-0.07 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.6M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $607.0M | $417.3M |
| Total Assets | $892.9M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.6M | — | ||
| Q3 25 | $31.4M | — | ||
| Q2 25 | $29.4M | — | ||
| Q1 25 | $30.2M | $67.8M | ||
| Q4 24 | $41.1M | $101.2M | ||
| Q3 24 | $40.9M | $78.0M | ||
| Q2 24 | $30.2M | $185.3M | ||
| Q1 24 | $34.2M | $68.4M |
| Q4 25 | $607.0M | — | ||
| Q3 25 | $615.3M | — | ||
| Q2 25 | $624.7M | — | ||
| Q1 25 | $633.4M | $417.3M | ||
| Q4 24 | $655.9M | $428.7M | ||
| Q3 24 | $665.4M | $422.4M | ||
| Q2 24 | $682.1M | $429.9M | ||
| Q1 24 | $703.9M | $269.4M |
| Q4 25 | $892.9M | — | ||
| Q3 25 | $901.0M | — | ||
| Q2 25 | $903.2M | — | ||
| Q1 25 | $916.4M | $486.5M | ||
| Q4 24 | $946.9M | $526.3M | ||
| Q3 24 | $981.5M | $554.6M | ||
| Q2 24 | $1.0B | $582.0M | ||
| Q1 24 | $1.0B | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.8M | $-38.5M |
| Free Cash FlowOCF − Capex | $-12.7M | $-39.7M |
| FCF MarginFCF / Revenue | -48.6% | -192.9% |
| Capex IntensityCapex / Revenue | 63.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.3M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | — | ||
| Q3 25 | $8.3M | — | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $-5.5M | $-38.5M | ||
| Q4 24 | $9.0M | $-31.6M | ||
| Q3 24 | $14.5M | $-24.3M | ||
| Q2 24 | $-648.0K | $39.8M | ||
| Q1 24 | $-7.1M | $-25.5M |
| Q4 25 | $-12.7M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-9.9M | $-39.7M | ||
| Q4 24 | $-16.2M | $-32.2M | ||
| Q3 24 | $8.6M | $-24.9M | ||
| Q2 24 | $-5.1M | $38.8M | ||
| Q1 24 | $-15.8M | $-26.4M |
| Q4 25 | -48.6% | — | ||
| Q3 25 | 11.0% | — | ||
| Q2 25 | -21.5% | — | ||
| Q1 25 | -36.7% | -192.9% | ||
| Q4 24 | -57.2% | -86.2% | ||
| Q3 24 | 29.1% | -127.3% | ||
| Q2 24 | -16.7% | 41.0% | ||
| Q1 24 | -50.8% | -44.6% |
| Q4 25 | 63.0% | — | ||
| Q3 25 | 19.4% | — | ||
| Q2 25 | 10.7% | — | ||
| Q1 25 | 16.4% | 5.6% | ||
| Q4 24 | 88.9% | 1.7% | ||
| Q3 24 | 19.6% | 3.3% | ||
| Q2 24 | 14.6% | 1.1% | ||
| Q1 24 | 28.1% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
